Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study.
Marín-Jiménez I, Acosta MB, Esteve M, Castro-Laria L, García-López S, Ceballos D, Echarri A, Martín-Arranz MD, Busquets D, Llaó J, Navarro-Llavat M, Huguet JM, Argüelles-Arias F, Vicente R, Boudet JM, Díaz G, Sánchez-Migallón AM, Casellas F; for RAPIDA trial investigators. Marín-Jiménez I, et al. Among authors: acosta mb. Gastroenterol Hepatol. 2022 Mar;45(3):165-176. doi: 10.1016/j.gastrohep.2021.04.010. Epub 2021 May 27. Gastroenterol Hepatol. 2022. PMID: 34051313 Clinical Trial. English, Spanish.
Relationship between IGF-1 and body weight in inflammatory bowel diseases: Cellular and molecular mechanisms involved.
Guijarro LG, Cano-Martínez D, Toledo-Lobo MV, Salinas PS, Chaparro M, Gómez-Lahoz AM, Zoullas S, Rodríguez-Torres R, Román ID, Monasor LS, Ruiz-Llorente L, Del Carmen Boyano-Adánez M, Guerra I, Iborra M, Cabriada JL, Bujanda L, Taxonera C, García-Sánchez V, Marín-Jiménez I, Acosta MB, Vera I, Martín-Arranz MD, Mesonero F, Sempere L, Gomollón F, Hinojosa J, Alvarez-Mon M, Gisbert JP, Ortega MA, Hernández-Breijo B, On Behalf Of The Predicrohn Study Group From Geteccu. Guijarro LG, et al. Among authors: acosta mb. Biomed Pharmacother. 2021 Dec;144:112239. doi: 10.1016/j.biopha.2021.112239. Epub 2021 Sep 30. Biomed Pharmacother. 2021. PMID: 34601192 Free article.
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Peyrin-Biroulet L, Rahier JF, Kirchgesner J, Abitbol V, Shaji S, Armuzzi A, Karmiris K, Gisbert JP, Bossuyt P, Helwig U, Burisch J, Yanai H, Doherty GA, Magro F, Molnar T, Löwenberg M, Halfvarson J, Zagorowicz E, Rousseau H, Baumann C, Baert F, Beaugerie L; I-CARE Collaborator Group. Peyrin-Biroulet L, et al. Clin Gastroenterol Hepatol. 2023 Mar;21(3):771-788.e10. doi: 10.1016/j.cgh.2022.09.018. Epub 2022 Sep 22. Clin Gastroenterol Hepatol. 2023. PMID: 36152897 Free article.
Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis on sexuality and inflammatory bowel disease.
Calvo Moya M, Mesonero Gismero F, Suarez Ferrer C, Hernández-Camba A, Vásquez Carlón D, García Benasach F, Aguas Peris M, Delgado Oliva FJ, González-Lama Y, Millán Scheiding M, Alonso Sebastián I, Camacho Martel L, Gallardo Arriero V, Echarri Piudo A, Bella Castillo P, Cano Sanz N, Vera Mendoza MI, Serrano Labajos R, Valdivia Martínez A, Pérez Restoy L, Zabana Abdo Y, Mañosa Ciria M, Rodríguez-Moranta F, Barreiro-de Acosta M, Gutiérrez Casbas A; en representación de GETECCU. Calvo Moya M, et al. Gastroenterol Hepatol. 2024 Jan 11:S0210-5705(24)00019-0. doi: 10.1016/j.gastrohep.2023.12.013. Online ahead of print. Gastroenterol Hepatol. 2024. PMID: 38218430 Free article. English, Spanish.
Combinación de granulocito-monocito aféresis y ustekinumab: estudio multicéntrico y retrospectivo.
Lago IR, de Guise CH, Watts MB, Rodríguez C, Carnerero EL, Íñiguez MC, Cañete F, Chacón S, Cuarán C, Elorza A, Del-Río EG, Iglesias E, Sánchez D, de Acosta MB, Ginard D, Cabriada JL. Lago IR, et al. Among authors: de acosta mb. Gastroenterol Hepatol. 2024 May 4:502195. doi: 10.1016/j.gastrohep.2024.502195. Online ahead of print. Gastroenterol Hepatol. 2024. PMID: 38710466 English, Spanish.
EFFICACY AND SAFETY OF BIOLOGICAL TREATMENT FOR INFLAMMATORY BOWEL DISEASE IN ELDERLY PATIENTS: RESULTS FROM A GETECCU COHORT.
Ferrer CS, Gismero FM, Caballol B, Ballester MP, Rey IB, García AC, Bautista JM, Chumillas RS, Benitez JM, Delgado LS, García AL, de Celix CR, Abreu IA, Melcarne L, Santos RP, Camí MM, Mateos AC, Díez CG, Calafat M, Galan HA, Vilaamil PV, Senosiain BC, Moya AG, Rodriguez Diaz CY, Spicakova K, Marcos NM, Molina G, Castro Parga L, Angulo AR, Del Campo LC, Rodriguez Grau MDC, Ramirez F, Pastrana BG, Partida IG, Mateu BB, Gonzalez EP, Iyo E, Gonzalez AE, Arnau ES, Villalba LH, Galindo PP, Medina LT, Alonso SM, Olmos Perez JA, Sadornil CD, Ramirez LG, Martín-Arranz MD, Sanroman AL, Fernández A, Murgui VM, Suárez CC, Florez P, Lobato Matilla ME, Sicilia B, Escribano PS, Martin CM, Mañosa M, De Acosta MB; On belhaf of Young group of GETECCU. Ferrer CS, et al. Among authors: de acosta mb. Gastroenterol Hepatol. 2024 May 4:502197. doi: 10.1016/j.gastrohep.2024.502197. Online ahead of print. Gastroenterol Hepatol. 2024. PMID: 38710465 English, Spanish.
IMPACT OF MESALAZINE ON THE RESPONSE TO COVID-19 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. RESULTS OF A PROSPECTIVE MULTICENTRE STUDY OF GETECCU (VACOVEII STUDY).
Deza DC, Julián Gomara AB, Biota EC, Beltrán B, Domènech E, Casbas AG, Mañosa M, Zabana Y, Alfaro LR, Romero EV, González EG, Sicilia B, Laredo V, Alcalá Escriche MJ, Velázquez LM, Iglesias RF, Pérez AP, Calafat M, Iturria SR, Yudego IM, Nieto YB, Mateo SG, Gisbert JP, Lidón RV, Arias L, Alfambra E, Roche PC, de Acosta MB, López SG. Deza DC, et al. Among authors: de acosta mb. Gastroenterol Hepatol. 2024 Jan 12:S0210-5705(24)00017-7. doi: 10.1016/j.gastrohep.2023.12.012. Online ahead of print. Gastroenterol Hepatol. 2024. PMID: 38219960 English, Spanish.
19 results